During clinical trials in hypertensive patients with benazepril,. Anaphylactoid Reactions During Desensitization: Two patients undergoing desensitizing treatment with hymenoptera venom while receiving ACE inhibitors sustained life-threatening anaphylactoid reactions. Lotensin has been used concomitantly with beta-adrenergic-blocking agents, calcium-channel-blocking agents, diuretics, digoxin, and hydralazine, without evidence of clinically important adverse interactions. Specifically, participants who, for three years, took ACE inhibitors that do not cross the blood-brain barrier were at 73 percent greater risk of developing dementia than were the individuals taking other anti-hypertensive drugs. Patients receiving ACE inhibitors who develop jaundice or marked elevations of hepatic enzymes should discontinue benazepril cash on delivery the ACE inhibitor and receive appropriate medical follow-up. If angioedema of the face, extremities, lips, tongue, or glottis and or larynx occurs, treatment with Lotensin should be discontinued and appropriate therapy instituted immediately see WARNINGS. There are several different causes of dementia, but Alzheimer disease and strokes are two of the most common.